ADPT
Adaptive Biotechnologies Corp
NASDAQ: ADPT · HEALTHCARE · BIOTECHNOLOGY
$13.53
-3.63% today
Updated 2026-04-29
Market cap
$2.16B
P/E ratio
—
P/S ratio
7.80x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$8 – $21
Volume
1.9M
Adaptive Biotechnologies Corp (ADPT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$13.53
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$32.68
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -21.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.